Study of Stress Hyperglycemia as an Indicator of Diabetes Mellitus
Stopped early
Conditions studied: Stress Hyperglycemia, Diabetes Mellitus Type 2
In brief
We hypothesize that stress hyperglycemia is an indicator that a patient will develop type 2 diabetes mellitus in the future. Subjects who are not diabetic are enrolled and blood glucose readings reviewed during their intensive care unit stay. All subjects are consented and have a HbA1C level drawn to determine if they have diabetes mellitus or not. They are then followed up in 1 year and the HbA1C repeated to determine if they have developed diabetes mellitus over the course.
Key facts
- Study ID
- NCT02068989
- Run by
- Yale University
- People needed
- 1
- Starts
- 2013-02-01
- Expected to finish
- 2015-03-01
- Last updated by the study team
- 2016-09-05
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- All patients admitted to the intensive care unit at the Yale New Haven Hospital St. Raphael Campus and Norwalk Hospital
You may not qualify if…
- Patients with prior history of diabetes mellitus
- Elevated admission HbA1c (≥6.5%)
- Age >80 years
- Metastatic disease with expected life expectancy of less than 12 months
- Pregnancy or a woman who plans to become pregnant
Where it is running
- Yale New Haven Hospital St. Raphael Campus — New Haven, Connecticut, United States
- Norwalk Hospital — Norwalk, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.